Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Matched Cohort Comparison Indicates Superiority of Precurved Electrode Arrays

Holder, Jourdan T.*; Yawn, Robert J.; Nassiri, Ashley M.; Dwyer, Robert T.*; Rivas, Alejandro; Labadie, Robert F.; Gifford, René H.*

doi: 10.1097/MAO.0000000000002366
Featured on Facebook
Featured on Twitter

Objective: Characterize differences in adult cochlear implant outcomes and programming parameters for a straight (CI422/522) and a precurved (CI532) electrode array.

Setting: Cochlear implant (CI) program at a tertiary otologic center.

Patients: Fifty-eight adults were included in the study; 29 were implanted with CI422 or CI522 and 29 were implanted with CI532. Each CI532 recipient was matched to a CI422/522 recipient in terms of age and preoperative hearing thresholds for comparison purposes.

Main Outcome Measures: Consonant-Nucleus-Consonant (CNC) words, AzBio sentences, residual audiometric thresholds, and Speech Spatial Qualities (SSQ) questionnaire collected 6 months postoperatively were used to characterize outcomes. Pulse duration, maxima, impedances, and overall charge measurements were used to characterize programming parameters.

Results: Postoperative unaided low frequency pure-tone average (LFPTA) was significantly better for the CI532 group. CNC scores were significantly better for the CI532 group. Impedances and pulse duration were significantly lower for the CI532 group, but there was no difference in overall charge between the groups.

Conclusion: The CI532 group showed either similar or statistically superior results on all measures when compared with the CI422/522 suggesting that the CI532 electrode may be an advantageous substitute for the CI522.

*Department of Hearing and Speech Sciences

Department of Otolaryngology–Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee

Address correspondence and reprint requests to Jourdan T. Holder, Au.D., Department of Hearing and Speech Sciences, 1215 21st Avenue South, Medical Center East, South Tower, #9302, Nashville, TN 37232-8605; E-mail:

Institutional Review Board Approval: Vanderbilt University IRB Approval: 140152.

Financial Material & Support: NIH R01 DC13117 – PI: René Gifford.

René Gifford: Advisory board for Advanced Bionics, Cochlear, and Frequency Therapeutics, Robert Labadie: Consultant for Advanced Bionics, Johnson & Johnson, and Ototronix, Alejandro Rivas: Consultant for Med-El, Advanced Bionics, Cochlear, Grace Medical, Stryker, and Cook Medical.

Copyright © 2019 by Otology & Neurotology, Inc. Image copyright © 2010 Wolters Kluwer Health/Anatomical Chart Company